Statements (52)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:Company
|
| gptkbp:bfsLayer |
4
|
| gptkbp:bfsParent |
gptkb:Perkin_Elmer
|
| gptkbp:acquired |
gptkb:Perkin_Elmer,_Inc.
|
| gptkbp:employs |
gptkb:architect
gptkb:physicist Sales professionals |
| gptkbp:focuses_on |
gptkb:Database_Management_System
gptkb:Company Pharmaceuticals Proteomics |
| gptkbp:founded |
1937
|
| gptkbp:has_part |
gptkb:Police_Department
Laboratory equipment Finance department Software solutions Reagents Manufacturing facilities Research and development department Human resources department Information technology department Quality control department Sales and marketing department Supply chain management department Corporate communications department Customer support department Regulatory affairs department Environmental health and safety department |
| gptkbp:has_product |
Imaging systems
Cell culture products Flow cytometers Mass spectrometers Bioreagents Chromatography systems Microplate readers Diagnostic kits PCR systems |
| gptkbp:has_website |
www.perkinelmer.com
|
| gptkbp:headquarters |
gptkb:Waltham,_Massachusetts
|
| https://www.w3.org/2000/01/rdf-schema#label |
Perkin Elmer Life Sciences
|
| gptkbp:industry |
Life Sciences
|
| gptkbp:is_part_of |
gptkb:Perkin_Elmer,_Inc.
|
| gptkbp:market_cap |
$10 billion
|
| gptkbp:offers |
Laboratory services
Analytical instruments Diagnostic solutions |
| gptkbp:revenue |
$2 billion
|
| gptkbp:serves |
Research institutions
Healthcare industry Pharmaceutical companies |
| gptkbp:subsidiary |
gptkb:Perkin_Elmer_Diagnostics
gptkb:Perkin_Elmer_Genomics |